Atrás
Sequana Medical NV (SQNMF) Ganando
Gráfico del Precio de Acciones SQNMF
SQNMF Ganando
Sequana Medical NV
$0
0%
$0
Al cierre: Mar 27, 16:00:00 GMT-4
$1.22
0%
$0
Mercado Posterior: Mar 27, 20:00:00 GMT-4
Earnings FAQ
¿Cómo se comparó el EPS reciente de SQNMF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Sequana Medical NV SQNMF en el último trimestre?
¿Cuál es la estimación de ingresos para Sequana Medical NV?
¿Cuál es la puntuación de calidad de ganancias de Sequana Medical NV?
¿Cuándo informa Sequana Medical NV sus ganancias?
¿Cuáles son las ganancias esperadas de Sequana Medical NV?
¿Superó Sequana Medical NV las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
--
Precio de apertura
--
Rango del día
-
Rango de 52 semanas
$0.78 - $3
Volumen
--
Volumen promedio
350
Rendimiento de dividendos
--
EPS (TTM)
--
Cap. de mercado
$83.0M
¿Qué es SEQUANA MEDICAL NV?
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.